1 option
Update on the SNG001 drug, an INFbeta therapy for COVID-19 / an interview with Stephen Holgate.
- Format:
- Sound recording
- Author/Creator:
- Holgate, S. T., Speaker.
- Series:
- Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
- Interviews on Covid-19, 2056-452X
- Language:
- English
- Subjects (All):
- Antiviral agents--Development.
- Antiviral agents.
- Clinical trials.
- Coronavirus infections--Chemotherapy.
- Coronavirus infections.
- COVID-19 (Disease)--Prevention.
- COVID-19 (Disease).
- COVID-19 (Disease)--Treatment.
- Interferon.
- Antiviral Agents--administration & dosage.
- Clinical Trials, Phase II as Topic.
- Coronavirus Infections--drug therapy.
- Coronavirus Infections--prevention & control.
- COVID-19 Drug Treatment.
- COVID-19--prevention & control.
- Interferon-beta--administration & dosage.
- Interferon-beta--therapeutic use.
- Nebulizers and Vaporizers.
- Pneumonia, Viral--drug therapy.
- Pneumonia, Viral--prevention & control.
- Precision Medicine.
- SARS-CoV-2.
- Treatment Outcome.
- Medical Subjects:
- Antiviral Agents--administration & dosage.
- Clinical Trials, Phase II as Topic.
- Coronavirus Infections--drug therapy.
- Coronavirus Infections--prevention & control.
- COVID-19 Drug Treatment.
- COVID-19--prevention & control.
- Interferon-beta--administration & dosage.
- Interferon-beta--therapeutic use.
- Nebulizers and Vaporizers.
- Pneumonia, Viral--drug therapy.
- Pneumonia, Viral--prevention & control.
- Precision Medicine.
- SARS-CoV-2.
- Treatment Outcome.
- Physical Description:
- 1 online resource (1 streaming audio file (13 min., 06 sec.))
- Other Title:
- Update on the SNG001 drug, an INFβ therapy for COVID-19
- Update on the SNG001 drug, an Interferon-beta therapy for COVID-19
- Place of Publication:
- London : Henry Stewart Talks, 2020.
- System Details:
- video file
- Contents:
- Contents: An overview of SNG001 therapy
- Findings of the phase 2 clinical trial
- Treatment potential at different stages of the disease
- Advantages of the treatment delivery mode and accessibility
- Potential use as a prophylaxis treatment
- Follow up clinical trials to be undertaken
- Other treatment settings for INFβ.
- Notes:
- Description based on: online resource; title from information screen (HSTalks, viewed April 14, 2024).
- Audio interview.
- Title from title frames.
- Publisher Number:
- 8204 Henry Stewart Talks
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.